companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

KRENNING HOLDINGS

CAMROSE-Canada

Company Name:
Corporate Name:
KRENNING HOLDINGS
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 4725 65 St,CAMROSE,AB,Canada 
ZIP Code:
Postal Code:
T4V3M5 
Telephone Number: 7806729666 
Fax Number:  
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
653108 
USA SIC Description:
Real Estate Management 
Number of Employees:
1 to 4 
Sales Amount:
$500,000 to $1 million 
Credit History:
Credit Report:
Good 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
KROEGER FINANCIAL SERVICES
KROEGER FINANCIAL SVC
KRM HEATING & VENTILATION
Next company profile:
KOT & TWERDUN
KOBE CLASSIC BEEF
KNUDSON FURNACE & DUCT CLEAN










Company News:
  • Treating Myelodysplastic Syndromes | MDS Treatment
    Treating Myelodysplastic Syndromes If you’ve been diagnosed with a myelodysplastic syndrome (MDS), your treatment team will discuss your options with you It’s important to weigh the benefits of each treatment option against the possible risks and side effects
  • Myelodysplastic syndromes - Diagnosis and treatment - Mayo Clinic
    Bone marrow transplant A bone marrow transplant, also known as a stem cell transplant, is the only treatment option that offers the potential of a cure for myelodysplastic syndromes But this treatment carries a high risk of serious complications and it's generally reserved for people who are healthy enough to endure it
  • Myelodysplastic Syndromes Treatment - NCI
    Myelodysplastic syndromes (MDS) treatment options include supportive care, drug therapy, and chemotherapy with allogeneic stem cell transplant Learn more about newly diagnosed or recurrent MDS and its treatment in this expert-reviewed summary
  • 3 Innovative Myelodysplastic Syndrome Treatment Options | MD . . .
    Lower-risk myelodysplastic syndrome patients are treated initially for the specific complications of the disease, such as anemia and low blood counts If more aggressive therapy is needed, strategies that are considered standard of care include chemotherapy using hypomethylating agents (5-azacitidine and decitabine) and lenalidomide
  • MDS Disease Treatment: 7 Key Options for Myelodysplastic . . .
    MDS Disease Treatment: 7 Key Options for Myelodysplastic Syndrome Management At Liv Hospital, we know managing myelodysplastic syndromes (MDS) needs a detailed and personal plan MDS are disorders where the bone marrow makes badly formed or immature blood cells So, finding the right myelodysplastic syndrome therapy is key to better patient
  • Treatment for Myelodysplastic Syndrome (MDS) | Memorial Sloan . . .
    Doctors at Memorial Sloan Kettering are experts in treating myelodysplastic syndrome (MDS) Learn more about treatment options for MDS
  • How We Treat Myelodysplastic Syndromes (MDS) | Dana-Farber . . .
    Your treatment plan may depend on: Your age and overall health Your disease characteristics and presence of certain mutations Your risk of progressing from MDS to AML Your specific wishes, goals, and values Our team will work closely with you to discuss your treatment options, including possible clinical trials, and determine the best approach
  • NCCN Guidelines for Patients: Myelodysplastic Syndromes
    There is more than one treatment for lower-risk myelodysplastic syndrome (MDS) This chapter presents all of the treatment options recommended by NCCN MDS experts at this time
  • Treatment of MDS | Blood | American Society of Hematology
    The heterogeneous nature of myelodysplastic syndromes (MDS) demands a complex and personalized variety of therapeutic approaches Among them, allogeneic hematopoietic stem cell transplantation remains the only potentially curative option and is accessible to only a small number of fit patients For the majority of patients with MDS, treatment strategies are nonintensive and risk-adapted (by
  • First-Line Treatment for Patients With MDS: Moving Toward . . .
    First-line treatment options for anemia in lower-risk myelodysplastic syndrome include luspatercept and epoetin alfa, each offering distinct advantages Both remain important therapies, with selection guided by patient-specific characteristics




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer